April 29th 2025
The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.
April 24th 2025
April 22nd 2025
The commitment will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple states.
April 21st 2025
April 18th 2025
Calculating the amount of drug needed for compounding requires different considerations for respective drug types and forms.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Addressing Data Security with Claudio Fayad (Emerson Automation Exchange)
Claudio Fayad, VP of Technology, Process Systems, and Solutions discusses the intersection of automation and data security in the pharma industry.
Lonza and ABL Bio Collaborate on Bispecific Antibody Product
Lonza and ABL Bio are collaborating on the development and manufacture of bispecific antibody product.
NextPharma Acquires Chewable Tablets Manufacturing Site in Norway
NextPharma has acquired a leading European chewable tablets manufacturing site from Takeda in Asker, Norway.
Exploring Automation and Sustainability with Nathan Pettus (Emerson Automation Exchange)
Nathan Pettus, president of Process Systems and Solutions at Emerson, discusses how automation is impacting recent sustainability technologies and solutions.
Sartorius to Acquire Polyplus in $2.6 Billion Deal
Sartorius’ acquisition of Polyplus is designed to strengthen its cell and gene therapy capabilities.
Emerson Automation Exchange Highlights
Interviews hosted on-site at the Emerson Automation Exchange in Grapevine, Texas, from October 24th to October 28th, 2022.
Marrying RNA and Mass Spectrometry
Mass spectrometric techniques are providing insights in critical RNA-based therapeutic areas.
Suppliers’ Supply Chains and Continuous Manufacturing Pose Big Risks for US CDMOs
A CPHI North America panel discussion forewarns that CDMO supply chains are potentially the biggest single risk to product resilience.
Overcoming critical barriers when developing mRNA-based cell therapies
Webinar Date/Time: Tue, May 23, 2023 11:00 AM EDT
Balancing Change and Certainty in Manufacturing
As new manufacturing processes and technologies are introduced to meet demand and overcome challenges, understanding also needs to improve to ensure the right balance is achieved.
Quality Challenges Associated with Cryo/Lyoprotectants
Impurities and batch-to-batch variability present the biggest challenges.
Small Footprint Automated Closed Production Platforms for CAR-T and Other Advanced Therapies
Limitations in production platforms have impeded continuous manufacturing for advanced therapies.
Packaging Becomes More Sustainable
Manufacturers and suppliers join forces to reduce the pharmaceutical industry’s carbon footprint.
Accepting Alternative Approaches to Freeze Drying
Alternative approaches to freeze-drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.
Contract Testing Services Solidify Their Place in the Manufacturing Value Chain
Contract testing services demonstrate a major increase in the speed and efficiency of testing using new testing methods and technologies.
Multi-Agitator Low-to-Medium Viscosity Mixer
The ROSS Model CDA-200 is fitted with multiple agitators for semi-continuous operation.
High-Performance Spectrometer
The Thermo Fisher Scientific Nicolet Summit X FTIR Spectrometer is a high-performance system designed for flexibility, ease of use, and high productivity.
Cytometry Application Dyes
Bio-Rad Laboratories StarBright Blue and StarBright Yellow dyes are conjugated to flow validated antibodies, supporting flow cytometry panel design in immunology design.
Automated mRNA Synthesis Kit
High-titre Vector Producing Cells
Decreasing vein to vein time saves lives.
Exothera Partners with Remedium to Scale-Up Manufacturing of Gene Therapy Drug Candidate
CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.
Takeda to Invest ¥100 Billion (US$754 Million) into New Plasma Therapy Manufacturing Facility
Takeda plans to build a new facility in Osaka, Japan, for the manufacture of plasma-derived therapies.
Process Optimization for Monoclonal Antibody (mAb) Commercial Manufacturing
Webinar Date/Time: Tue, Apr 25, 2023 11:00 AM EDT
Curia and Corning Collaborate to Advance Biopharmaceutical Continuous-Flow Development
Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.
PurePep EasyClean Services Set to Accelerate Development and Manufacturing of Peptide-based Drugs
The services are based on the company’s PurePrep EasyClean (PEC) orthogonal peptide purification technology.
Sartorius and Teknova Team Up for Gene Therapy Process Development
Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.
Samsung Biologics to Build Plant 5 as Part of Capacity Expansion to Bio Campus II
Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.
Stevanato Group and Recipharm to Collaborate on Pre-fillable Syringes for Soft Mist Inhaler
Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.
Modern Modelling Tools for Small Molecule Solid Dose Manufacturing
Webinar Date/Time: Tue, Apr 18, 2023 11:00 AM EDT
Sandoz to Build New Biologics Production Facility in Slovenia
Sandoz, a Novartis division, is expected to invest at least $400 million to build a new biologics manufacturing facility in Lendava, Slovenia, to support growing demand for biosimilars.